Ocular Therapeutix
OCUL
OCUL
106 hedge funds and large institutions have $321M invested in Ocular Therapeutix in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 53 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
18% more funds holding
Funds holding: 90 → 106 (+16)
7.44% more ownership
Funds ownership: 54.18% → 61.62% (+7.4%)
Holders
106
Holding in Top 10
7
Calls
$4.72M
Puts
$2.18M
Top Buyers
| 1 | +$18.1M | |
| 2 | +$6.01M | |
| 3 | +$5.71M | |
| 4 |
BlackRock
New York
|
+$5.02M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$5.01M |
Top Sellers
| 1 | -$6.58M | |
| 2 | -$2.1M | |
| 3 | -$161K | |
| 4 |
Jane Street
New York
|
-$158K |
| 5 |
SI
Stephens Inc
Little Rock,
Arkansas
|
-$111K |